These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 6441856)
21. [Is rhesus prophylaxis indicated also with positive antibodies?]. Behrens O Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755 [No Abstract] [Full Text] [Related]
22. [Comment on H. Wilken: Current problems of blood group incompatibility in pregnancy, Zent.bl. Gynäkol. 110 (1988) 1-11]. Lahmann N Zentralbl Gynakol; 1989; 111(6):385-7. PubMed ID: 2499137 [No Abstract] [Full Text] [Related]
24. The global burden of Rh disease. Zipursky A; Paul VK Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F84-5. PubMed ID: 21037283 [No Abstract] [Full Text] [Related]
25. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security. Zavala C; Salamanca F Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398 [TBL] [Abstract][Full Text] [Related]
26. Rh immunization in Manitoba: progress in prevention and management. Bowman JM; Pollock J Can Med Assoc J; 1983 Aug; 129(4):343-5. PubMed ID: 6409390 [TBL] [Abstract][Full Text] [Related]
28. [Perinatal hemolytic disease caused by Rh incompatibility as a true social scourge. Interview between "Minerva Medica" and Professor Franco Gasparri]. Barraciu A Minerva Med; 1970 Dec; 61(102 Suppl):5-8. PubMed ID: 5497702 [No Abstract] [Full Text] [Related]
29. Haemolytic disease of the newborn: the new NICE guidelines. Thompson J J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064 [TBL] [Abstract][Full Text] [Related]
31. The prevention of Rh haemolytic disease of the fetus and newborn--general background. Contreras M Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972 [No Abstract] [Full Text] [Related]
32. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. de la Cámara C; Arrieta R; González A; Iglesias E; Omeñaca F N Engl J Med; 1988 Feb; 318(8):519-20. PubMed ID: 3123931 [No Abstract] [Full Text] [Related]
33. [Prevention of fetal hemolytic disease: it is time to take action]. Mannessier L; Alie-Daram S; Roubinet F; Brossard Y; Transfus Clin Biol; 2000 Dec; 7(6):527-32. PubMed ID: 11204837 [TBL] [Abstract][Full Text] [Related]
34. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction]. Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755 [TBL] [Abstract][Full Text] [Related]
35. "The use of Rh-immune globulin". Lavery JP Nebr Med J; 1987 May; 72(5):175-6. PubMed ID: 3035388 [No Abstract] [Full Text] [Related]
37. Haemolytic disease of the newborn--the changing scene. Tovey LA Br J Obstet Gynaecol; 1986 Sep; 93(9):960-6. PubMed ID: 3094573 [TBL] [Abstract][Full Text] [Related]
38. Some residual problems concerning Rh prophylaxis. Finn R Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):436-9. PubMed ID: 5003521 [No Abstract] [Full Text] [Related]
39. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn. Mills L; Napier JA Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774 [TBL] [Abstract][Full Text] [Related]